ZNF184 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.85940041141919E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.6135981439902E-11 |
Normal-vs-Stage2 |
1.924680E-03 |
Normal-vs-Stage3 |
1.475010E-01 |
Normal-vs-Stage4 |
8.26740000000603E-05 |
Stage1-vs-Stage2 |
3.968000E-01 |
Stage1-vs-Stage3 |
2.897200E-01 |
Stage1-vs-Stage4 |
6.855000E-01 |
Stage2-vs-Stage3 |
5.837200E-01 |
Stage2-vs-Stage4 |
8.412600E-01 |
Stage3-vs-Stage4 |
4.704200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.26680032919558E-10 |
Normal-vs-AfricanAmerican |
5.90859999816118E-08 |
Normal-vs-Asian |
4.62189999994589E-06 |
Caucasian-vs-AfricanAmerican |
8.188000E-01 |
Caucasian-vs-Asian |
4.041900E-02 |
AfricanAmerican-vs-Asian |
3.202200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.09479980636706E-10 |
Normal-vs-Female |
1.47690000007472E-07 |
Male-vs-Female |
2.880800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.12350004247241E-09 |
Normal-vs-Extreme_Weight |
8.83881856594826E-12 |
Normal-vs-Obese |
5.34450000033715E-07 |
Normal-vs-Extreme_Obese |
5.919600E-03 |
Normal_Weight-vs-Extreme_Weight |
6.297600E-01 |
Normal_Weight-vs-Obese |
7.102400E-02 |
Normal_Weight-vs-Extreme_Obese |
9.324800E-01 |
Extreme_Weight-vs-Obese |
6.336400E-03 |
Extreme_Weight-vs-Extreme_Obese |
7.105600E-01 |
Obese-vs-Extreme_Obese |
3.393200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.00310000000914E-05 |
Normal-vs-Age(41-60Yrs) |
1.22279999459352E-08 |
Normal-vs-Age(61-80Yrs) |
4.93849960925274E-10 |
Normal-vs-Age(81-100Yrs) |
1.31730000019203E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.311600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.140400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.164000E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.755600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.646170E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.040400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.91390236992106E-11 |
Normal-VS-Type2 PRCC |
1.648350E-04 |
Normal-VS-KIRP CIMP |
8.2867000000042E-05 |
Normal-VS-Unclassified PRCC |
1.942870E-03 |
Type1 PRCC-VS-Type2 PRCC |
4.268000E-01 |
Type1 PRCC-VS-KIRP CIMP |
8.324800E-01 |
Type1 PRCC-VS-Unclassified PRCC |
1.966570E-01 |
Type2 PRCC-VS-KIRP CIMP |
7.066800E-01 |
Type2 PRCC-VS-Unclassified PRCC |
7.102000E-01 |
KIRP CIMP-VS-Unclassified PRCC |
5.698200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.84349979726051E-10 |
Normal-vs-N1 |
5.898600E-01 |
Normal-vs-N2 |
2.1016999999901E-05 |
N0-vs-N1 |
8.182000E-02 |
N0-vs-N2 |
4.209600E-01 |
N1-vs-N2 |
2.082100E-02 |
|
|